Teladoc Health, Inc. (NYSE:TDOC) Receives $7.50 Average PT from Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been given an average rating of “Hold” by the sixteen research firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $7.5357.

A number of brokerages have recently issued reports on TDOC. Citigroup reduced their price objective on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research note on Monday. Bank of America upped their target price on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a report on Tuesday, July 7th. Canaccord Genuity Group decreased their target price on Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, July 30th. Finally, Weiss Ratings upgraded shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 6,196 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $47,275.48. Following the completion of the transaction, the insider owned 57,671 shares of the company’s stock, valued at approximately $440,029.73. This trade represents a 9.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Fernando M. Rodrigues sold 5,677 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total value of $43,315.51. Following the completion of the sale, the insider owned 9,572 shares in the company, valued at $73,034.36. The trade was a 37.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 39,195 shares of company stock worth $299,058 in the last ninety days. 0.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently bought and sold shares of TDOC. IFP Advisors Inc lifted its position in Teladoc Health by 412.1% during the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 3,210 shares during the last quarter. PNC Financial Services Group Inc. raised its position in Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 2,810 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of Teladoc Health by 694.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 4,945 shares during the last quarter. International Assets Investment Management LLC purchased a new position in Teladoc Health during the fourth quarter worth $45,000. Finally, Versant Capital Management Inc grew its holdings in Teladoc Health by 33.3% during the 2nd quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider’s stock valued at $70,000 after purchasing an additional 2,052 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Up 0.7%

NYSE:TDOC opened at $6.72 on Friday. Teladoc Health has a twelve month low of $4.40 and a twelve month high of $9.89. The stock’s 50-day simple moving average is $8.22 and its 200 day simple moving average is $6.54. The firm has a market capitalization of $1.22 billion, a PE ratio of -6.79 and a beta of 2.12.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.04. The firm had revenue of $606.93 million during the quarter, compared to analyst estimates of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The business’s quarterly revenue was down 4.0% on a year-over-year basis. During the same period last year, the company posted ($0.19) EPS. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. On average, analysts anticipate that Teladoc Health will post -0.89 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.